Oregon Medicaid FFS Drug Class List


This is the Oregon Health Plan fee-for-service Preferred Drug List and drug prior authorization (PA) searchable database.

All active and available drugs reported by First DataBank are included if they provide a federal rebate or are preferred.

Drugs are assigned to a PDL class if it has been reviewed by the Oregon Pharmacy and Therapeutics Committee (P&T) for comparative effectiveness and safety. All other drugs are classified by default to the First DataBank Standard Therapeutic Class.

Drugs of higher effectiveness and/or safety or that are similar with lower cost are listed as preferred (Y). Drugs of lower effectiveness and /or safety or that are similar with higher cost are listed as non-preferred (N or V). Null (i.e. blank) indicates the class or specific drug has not been reviewed for PDL placement.

Non-preferred drugs listed as N require a PA for pharmacy payment. New drugs approved by the FDA exclusively for indications that are not funded by the Oregon Health Plan are subject to the Drugs for Non-funded Conditions criteria and all drugs in PDL classes are subject to clinical PA criteria when applicable. New drugs that are not subject to current clinical criteria and cost more than $5,000 per claim or $5,000 per month will be subject to the New Drug Policy until reviewed by the P&T Committee. For instructions on requesting a PA, see the Oregon Medicaid PA Criteria (you will need to scroll down to the PA section).

Non-preferred drugs listed as V (voluntary) do not require PA.

This page lists each drug class with links to the P&T meeting minutes where the class or drugs within the class were discussed. Further information on specific drugs can be found on the individual class page (click on the class name to be taken to its page). Alternatively you can search for individual drugs by brand or generic name.

Each individual drug class page lists any supporting documents presented at P&T for reference and lists the PDL status (Y, N, V or null) of each drug in the class. PA or QL (quantity limit) indicates the drug requires prior authorization for safety considerations or to promote appropriate step-therapy and links to the current approval criteria.

Drug Search
Search by brand name:
Search by generic name:
Limit search results to PDL Classes only:

Allergy/Cold
Class P&T Meeting Presented
Anaphylaxis Rescue
Antihistamines, First Generation
Antihistamines, Second Generation
Cough and Cold
Hereditary Angioedema
Nasal Allergy Inhalers
Topical Nasal and Otic
Analgesics
Class P&T Meeting Presented
CGRP Inhibitors
Gout
Misc Analgesics
Muscle Relaxants, Oral
Muscle Relaxants, Parenteral
Non-Steroidal Anti-Inflammatory Drugs
Opioids, Long-Acting
Opioids, Parenteral
Opioids, Short-Acting
Other Rheumatologic Agents
Pain Medications, Topical
Serotonin Agonists, Nasal
Serotonin Agonists, Oral
Serotonin Agonists, Subcutaneous
Anesthetics
Class P&T Meeting Presented
Anesthetics Gen Inhalant
Anesthetics Gen Injection
Antibiotics
Class P&T Meeting Presented
Amoxicillin and Clavulanate, Oral
Antibiotics, Vaginal
Cephalosporins (1st Gen), Oral
Cephalosporins (2nd Gen), Oral
Cephalosporins (3rd Gen), Oral
Cephalosporins, Parenteral
Chloramphenicol
Clostridioides difficile Drugs
Fluoroquinolones, Oral
Macrolides, Oral
Macrolides, Parenteral
Misc Antibiotics
Mycobacterium drugs
Oxazolidinones, Oral
Penicillin
Aug 07, 2025
Rifamycins
Streptomycins
Sulfonamides
TB Preps
Tetracyclines, Oral
Tetracyclines, Parenteral
Trimethoprim
Urinary Antibacterials, Analgesics
Antifungal
Class P&T Meeting Presented
Antifungals, Oral
Antifungals, Parenteral
Antifungals, Vaginal
Fungicides
Antiparasitics
Class P&T Meeting Presented
Antimalarials
Antiparasitics
Antivirals
Class P&T Meeting Presented
Coronavirus Antivirals
Hepatitis B
Hepatitis C, Direct-Acting Antivirals
Hepatitis C, Other Agents
Herpes Simplex
HIV
Influenza
Misc Antivirals
Cardiovascular
Class P&T Meeting Presented
Adrenergics
Antianginals
Anticoagulants, Intravenous
Anticoagulants, Oral and SQ
Beta-Blockers, Oral
Calcium Channel Blockers - Dihydropyridine, Oral
Calcium Channel Blockers - Non-Dihydropyridine, Oral
Cardiovascular Agents, Miscellaneous
Combination Antihypertensives
Digitalis Preps
Diuretics, Oral
Diuretics, Other
Inhibitors of the Renin-Angiotensin-Aldosterone System (RAAS)
Lipotropics
Other Dyslipidemia Drugs
Other Hypotensives
Platelet Inhibitors
Rauwolfias
Statins & Combos
Vasodilators: Coronary
Vasodilators: Peripheral
Dermatologicals
Class P&T Meeting Presented
Acne
Actinic Keratosis
All Other Dermatologicals
Allergens
Anesthetics Local Topical
Antibiotics, Topical
Anticholinergics, Topical
Antifungals, Topical
Antiparasitics, Topical
Antipruritics
General Actibacterial, Antibacterials
Moisturizers, Topical
Steroids, Topical
Topical Drugs for Molluscum Contagiosum
Topical Products for Inflammatory Skin Diseases
Diagnostics
Class P&T Meeting Presented
Diagnostics
Endocrine
Class P&T Meeting Presented
Anabolics
Androgens, Oral
Androgens, Topical & Parenteral
Antithyroid Preps
Bone Metabolism Drugs
Contraceptives
Corticoids Acth
Diabetes, DPP-4 Inhibitors
Diabetes, Emergency Therapy
Diabetes, GLP-1 Receptor Agonists and GIP Therapies
Diabetes, Glucagon
Diabetes, Insulins
Diabetes, Miscellaneous Antidiabetic Agents
Diabetes, SGLT-2 Inhibitors
Diabetes, Sulfonylureas
Diabetes, Thiazolidinediones
Estrogen Replacement, Oral
Estrogen Replacement, Topical
Estrogen Replacement, Vaginal
Estrogens, Parenteral
Glucocorticoids, Oral
Glucocorticoids, Other
GnRH Agonists
GnRH Antagonists
Growth Hormone Releasing Factor
Growth Hormones
Mineralocorticoids
Other Hormones
Progestational Agents
Thyroid Hormone, Oral
Thyroid Preps
Vitamin D Analogs
Weight Management Drugs
Gastrointestinal
Class P&T Meeting Presented
Antacid, H. pylori
Antacid, H2 Antagonists
Antacid, Misc
Antacid, Potassium-competitive
Antacid, Proton Pump Inhibitors
Antidiarrheals
Antiemetics, Conventional
Antiemetics, Newer
Antispasm Anticholinergics
Bile Therapy
Bile Therapy
Bowel Preparation Agents
Emetics
Hemorroidal Preps
Hyoscyamine
Inflammatory Bowel Disease
Laxatives, Bowel Preparation
Laxatives, Chronic Constipation
Pancreatic Enzymes
Genito-Urinary
Class P&T Meeting Presented
Benign Prostate Hypertrophy Drugs
Overactive Bladder Drugs
Hematology-Oncology
Class P&T Meeting Presented
Antihemophilia Factors
Antineoplastics, Newer
Antineoplastics, Older
Biologicals
Colony Stimulating Factors
Erythropoiesis Stimulating Agents
Hemostatics
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor
Iron Chelators
Sickle Cell Disease
Sickle Cell Gene Therapy
Thrombocytopenia Drugs
Immunological
Class P&T Meeting Presented
Biologics for Rare Conditions
Hemophagocytic lymphohistiocytosis
Immunoglobulins
Immunosuppressants
Immunotherapy Desensitization, non-injectable
Monoclonal Antibodies for Lupus
Targeted Immune Modulators
Targeted Immune Modulators for Asthma and Atopic Dermatitis
Thyroid Eye Disease, Monoclonal Antibodies
Medical Supplies
Class P&T Meeting Presented
Medical Supplies
Metabolic Disorders
Class P&T Meeting Presented
Amyloidosis Agents
Lysosomal Storage Disorders
Phenylketonuria
Urea Cycle Disorders
Miscellaneous
Class P&T Meeting Presented
Antidotes
Iodine Therapy
Miscellaneous
Orphan Drug
Oxytocics
Unassigned Drugs
Vaginal Cleansers
Neurology
Class P&T Meeting Presented
Agents for Hypersomnolence
Alzheimer's Disease, Non-injectable Drugs
Alzheimer's Disease, Targeted Drugs
Amyotrophic Lateral Sclerosis
Antiepileptics, Outpatient
Antiepileptics, Parenteral
Botulinum Toxins
Duchenne Muscular Dystrophy
Multiple Sclerosis
Parasympathetic Agents
Parkinson's Disease Drugs, Oral & Topical
Parkinson's Disease Drugs, Parenteral
Potassium Channel Blockers
Spinal Muscular Atrophy
Vesicular Monoamine Transporter Inhibitors
Nutritional
Class P&T Meeting Presented
Pediatric Multivitamins
B Complex with Vitamin C
B-vitamins, Oral
Calcium/Vit D Replacement, Oral
Digestants
Enzymes
Fat Soluble Vitamins and Analogs
Iron Replacemant & Hematinics, Not Oral
Iron Replacement, Oral
IV Solutions and Misc
Magnesium Replacement, Oral
Multivitamins, Oral
Parenteral Vitamins
Potassium and K-Phos, Oral
Prenatal Vitamins
Protein Lysates
Vitamin K
Water Soluble Vitamins, Parenteral
Ophthalmics
Class P&T Meeting Presented
Antibiotics, Ophthalmic
Antibiotic-Steroids, Ophthalmic
Anti-Inflammatory Drugs, Ophthalmic
Complement Inhibitors, Ophthalmic
Drugs for Dry Eye
Glaucoma Drugs
Misc Opthalmic Preparations
Vascular Endothelial Growth Factors
Otics
Class P&T Meeting Presented
Otic Antibiotics
Psychiatric
Class P&T Meeting Presented
ADHD Drugs
Antidepressants
Antidepressants, Misc. and Lithium
Antipsychotics, 1st Gen
Antipsychotics, 2nd Gen
Antipsychotics, Parenteral
Benzodiazepines
Opioid Reversal Agents
Sedative, Barbiturate
Sedative, Misc
Sedatives
Stimulants, Misc
Substance Use Disorders, Opioid & Alcohol
Tobacco Smoking Cessation
Tranquilizers, Misc
Pulmonary
Class P&T Meeting Presented
Beta-Agonists, Inhaled Long Acting
Beta-Agonists, Inhaled Short-Acting
Bronchial Dilators, Misc
Corticosteroids, Inhaled
Corticosteroids/Beta-Agonist Combination, Inhaled
Cystic Fibrosis
Interstitial Lung Disease
LAMA/LABA Combination, Inhalers
Miscellaneous Pulmonary Agents
Muscarinic Antagonists, Inhaled
Pulmonary Arterial Hypertension Oral and Inhaled Drugs
Pulmonary Arterial Hypertension Parenteral Drugs
Xanthine Derivatives
Renal
Class P&T Meeting Presented
Nephropathic Cystinosis
Phosphate Binders & Absorption Inhibitors
Potassium Exchangers
Last Update: 4:28am on Wednesday October 1st, 2025